AFOSR plans, coordinates, and executes the Air Force Research Laboratory’s (AFRL) basic research program in response to technical guidance from AFRL and requirements of the Air Force. Additionally, the office fosters, supports, and conducts research within Air Force, university, and industry laboratories; and ensures transition of research results to support U.S. Air Force needs.

The focus of AFOSR is on research areas that offer significant and comprehensive benefits to our national war fighting and peacekeeping capabilities. These areas are organized and managed in two scientific Departments: Engineering and Information Science (RTA) and Physical and Biological Sciences (RTB). The research activities managed within each Department are summarized the Broad Agency Announcement, which can be downloaded at the funding opportunity announcement at Grants.gov. Once you have navigated to the opportunity, click on the “Related Documents” Tab and select the Full Announcement, which can be downloaded as a .zip or .pdf file (see below).

The NIH is deeply concerned for the health and safety of people involved in NIH research, and about the effects on the biomedical enterprise in the areas affected by the HHS declared public health emergency for COVID-19. Due to the potential exceptional impact, we want to assure our recipient community that NIH will be doing our part to help you continue your research.

This is a rapidly evolving situation and we will provide updated guidance and information as it becomes available.

See page update history.

Guidance

Overview

• Overview presentation (Powerpoint) – updated 4/21/2020
• Overview talking points (Word) – updated 4/21/2020

Proposal Submission & Award Management

• UPDATE: NIH Late Application Policy Due to Public Health Emergency for United States for 2019 Novel Coronavirus (COVID-19) – NOT-OD-20-091
• General Frequently Asked Questions (FAQs) – Proposal Submission and Award Management Related to COVID-19 – NOT-OD-20-083
• Flexibilities Available to Applicants and Recipients of Federal Financial Assistance Affected by COVID-19 – NOT-OD-20-086
• Guidance for Cost-Related Flexibilities Available to Support of Competitive Research (SCORE) Award Recipients Affected by COVID-19 – NOT-GM-20-026
• Contracts must be handled on a case by case basis. Details regarding any contract must be directed to the cognizant Contracting Officer. Salary changes must be handled by the contracting officer.

Human Subjects & Clinical Trials

• Guidance for NIH-funded Clinical Trials and Human Subjects Studies Affected by COVID-19 – NOT-OD-20-087
• FDA Guidance on Conduct of Clinical Trials of Medical Products during COVID-19 Pandemic
• OHRP COVID-19 Resources
  • OHRP Guidance on COVID-19
  • Live Videocast on Tuesday, April 28 from 1-2pm ET
• Considerations for New and Ongoing Human Subjects Research During the COVID-19 Public Health Emergency (Word) – 4/24/2020

Animal Welfare

• COVID-19 Pandemic Contingency Planning for Animal Care and Use Programs
• Flexibilities for Assured Institutions for Activities of Institutional Animal Care and Use Committees (IACUCs) Due to COVID-19 – NOT-OD-20-088

Peer Review

• Coronavirus Update: Guidance for Peer Reviewers
• Based on NIH Guidance on Travel and Meetings, in-person NIH peer review meetings are being held in alternate formats. Scientific review officers will be in contact with peer reviewers about these changes.

FAQs – FAQs last updated on April 20, 2020 (history).

• NIH FAQs: COVID-19 Flexibilities for Applicants and Recipients

Funding

COVID-19 Funding and Funding Opportunities – Open Mike Blog

Funding Opportunities Specific to COVID-19

• Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions and Administrative Supplements to Clinical and Translational Science Award (CTSA) Program Awards to Address 2019 Novel Coronavirus Disease (COVID-19) Public Health Needs (Posted April 23, 2020)
• Notice of Special Interest:  Availability of Administrative Supplements and Competitive Revision Supplements on Coronavirus Disease 2019 (COVID-19) within the Mission of NIAAA (Posted April 16, 2020)
• Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements for Research on Coronavirus Disease 2019 (COVID-19) (Posted April 16, 2020)
• Notice of Special Interest regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for the Establishment and Maintenance of a Research Database for Neurological Manifestations of the SARS-CoV-2 (Posted April 14, 2020)
• Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus and the Behavioral and Social Sciences (Posted April 13, 2020)
• Notice of Special Interest (NOSI): NIEHS Support for Understanding the Impact of Environmental Exposures on Coronavirus Disease 2019 (COVID-19) (Posted April 10, 2020)
• Notice of Early Expiration of NOT-ES-20-015, “Notice of Special Interest (NOSI): NIEHS Support for Understanding the Impact of Environmental Exposures on Coronavirus Disease 2019 (COVID-19) (Posted April 10, 2020)
• NIEHS Worker Training Program Coronavirus and Infectious Disease Response Training (Admin Supp Clinical Trial Not Allowed) (Posted April 10, 2020)
• Notice of Early Expiration of “Notice of Special Interest (NOSI) regarding the NIEHS Worker Training Program Coronavirus and Infectious Disease Response Training (Admin Supp Clinical Trial Not Allowed)” (Posted April 10, 2020)
• Notice of Special Interest (NOSI): Availability of Emergency Competitive Revision and Administrative Supplements on Biomedical Technologies for Coronavirus Disease 2019 (COVID-19) (Posted April 10, 2020)
• Notice of Special Interest (NOSI): Development of Biomedical Technologies for Coronavirus Disease 2019 (COVID-19) (Posted April 10, 2020)
• Notice of Special Interest (NOSI): Small Business Research and Development of Biomedical Technologies for Coronavirus Disease 2019 (COVID-19) (Posted April 10, 2020)
• Notice of Special Interest (NOSI): Urgent Competitive Revisions to Accelerate Research on the Development of Predictive Models of the Spread of SARS-CoV-2 and Outcomes of Potential Public Health Interventions on COVID-19 (Posted April 10, 2020)
• Notice of Special Interest (NOSI): Availability of Administrative Supplements and Urgent Competitive Revisions for Research on Stress Management in Relation to Coronavirus Disease 2019 (COVID-19) (Posted April 10, 2020)
• Notice of Special Interest (NOSI): National Cancer Institute Announcement Regarding Availability of Urgent Competitive Revision and Administrative Supplements on Coronavirus Disease 2019 (COVID-19) (Posted April 10, 2020)
• Notice of Special Interest (NOSI): Availability of Urgent Competitive Revision Supplements on Coronavirus Disease 2019 (COVID-19) Related to HIV Comorbidities, Coinfections, and Complications within NIDDK’s Mission (Posted April 9, 2020)
• Notice of Special Interest (NOSI): Competitive and Administrative Supplements for the Impact of COVID-19 Outbreak on Minority Health and Health Disparities (Posted April 9, 2020)
• Notice of Special Interest (NOSI) regarding the Availability of Emergency Competitive Revisions to Existing NIH Grants and Cooperative Agreements for Tissue Chips Research on the 2019 Novel Coronavirus (Posted April 9, 2020)
• Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Mental Health Research on the 2019 Novel Coronavirus (Posted April 9, 2020)
• Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements for Tissue Chips Research on the 2019 Novel Coronavirus (Posted April 9, 2020)
• Notice of Special Interest (NOSI): National Cancer Institute Announcement regarding Availability of Competitive Revision SBIR/STTR Supplements on Coronavirus Disease 2019 (COVID-19) (Posted April 9, 2020)
• Notice of Special Interest (NOSI): NIEHS Support for Understanding the Impact of Environmental Exposures on Coronavirus Disease 2019 (COVID-19) (Posted April 9, 2020)
• Notice of Special Interest (NOSI): Availability of Urgent Competitive Revision Supplements on Coronavirus Disease 2019 (COVID-19) within the Mission of NIDDK (Posted April 9, 2020)
• Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions and Administrative Supplements for Research on Coronavirus Disease 2019 (COVID-19) April 20, 2020 Update (NOT-DC-20-006): Notice of Eligibility Change for NIDCD Urgent Competitive Revisions and Administrative Supplements for Research on COVID-19
• NHLBI Announces Availability of Frequently Asked Questions (FAQs) for NOT-HL-20-757, Notice of Special Interest (NOSI): Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19) (Posted April 8, 2020)
• Notice of Special Interest (NOSI): NIA Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19) April 21, 2020 Update (NOT-AG-20-031): Frequently Asked Questions for NOT-AG-20-022 Notice of Special Interest (NOSI): NIA Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19)
• Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus (Posted March 31, 2020)
• Notice of Special Interest: NIEHS Worker Training Program Coronavirus and Infectious Disease Response Training (Admin Supp Clinical Trial Not Allowed) (Posted March 27, 2020)
• Notice of Special Interest (NOSI): Repurposing Existing Therapeutics to Address the 2019 Novel Coronavirus Disease (COVID-19) (Posted March 27, 2020)
• Notice of Special Interest (NOSI) regarding the Availability of Emergency Competitive Revisions for Research on Severe Acute Respiratory Syndrome (Posted March 25, 2020)
• Notice of Early Expiration of “Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions for Research on the 2019 (Posted March 25, 2020)
• Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions for Research on Coronavirus Disease 2019 (COVID-19) and the Causative Virus SARS-CoV-2 (Posted March 25, 2020)
• Notice of Special Interest (NOSI) Clinical and Translational Science Award (CTSA) Program Applications to Address 2019 Novel Coronavirus (COVID-19) Public Health Need (Posted March 24, 2020)
• Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus (Posted March 19, 2020)
• Notice of Special Interest (NOSI): Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19) (Posted March 17, 2020)
• Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus (2019-nCoV) (Posted February 6, 2020)

Resources

• New NIH Resource to Analyze COVID-19 Literature: The COVID-19 Portfolio Tool
• Supporting Yourself and Your Trainees During the Coronavirus Pandemic Online Workshops
• NIH Office of Intramural Training & Education: Virtual NIH Activities for Trainees Outside the NIH
• NIH Website: Coronavirus Disease 2019 (COVID-19)
• CDC Website: Coronavirus Disease 2019 (COVID-19) including its guidance for Institutes of Higher Education and for mental health and coping
• WHO Website: Coronavirus disease (COVID-19) outbreak
• General Information on NIH Extramural Response to Natural Disasters and Other Emergencies

The Centers for Disease Control and Prevention (CDC) is deeply concerned for the health and safety of people involved in CDC-funded activities, and about the effects on the public’s health from Coronavirus Disease 2019 (COVID-19). Due to the potential scale of the declared public health emergency, we want to assure our grant and cooperative agreement recipient community that CDC will be doing our part to help you continue your work. CDC will support accelerated planning and operational readiness for COVID-19 preparedness and response, as well as develop tools and strategies, provide technical assistance and program support, and ensure ongoing communication and coordination among federal, state, local, tribal, and territorial public health agencies and partners throughout the response. This is a rapidly evolving situation, and we will continue to provide updated guidance and information as it becomes available.

CDC Resources

Funding For COVID-19

• CDC Crisis Response Mechanism for Funding State, Local, Territorial and Tribal (SLTT) Public Health Departments During a Public Health Response (TP-18-1802)
• Epidemiology and Laboratory Capacity for the Prevention and Control of Emerging Infectious Diseases (ELC) (CK19-1904 2019)
• COVID-19 Funding for Tribes
• CDC 24/7 Response and Support for COVID-19 Activities
• CARES Act Funding for States and Localities in Support of COVID-19 Response
• Overview of CDC Funding for COVID-19

Guidance

• Communication to State Health Officers: Immediate Plans for Coronavirus Disease 2019 Supplemental Funding to Jurisdictions
• Flexibilities Available to Applicants and Recipients of Federal Financial Assistance Affected by COVID-19
• Temporary Reassignment of Personnel

Award Terms and Conditions and Key Federal Regulations and Policies

• CDC Award Terms and Conditions and Federal Regulations and Policies

Frequently Asked Questions (FAQs)

• Novel Coronavirus (COVID-19) General Funding and Grants Frequently Asked Questions
• COVID-19 Effects on PHEP Requirements 3-17-20
• COVID-19 Supplemental Funding FAQs

CDC Information

• CDC Website: Coronavirus Disease 2019 (COVID-19)
• CDC: State and Local Readiness

The Ohio Department of Health offers grants relating to a variety of public health programs to organizations in Ohio, including county and local health departments.

Individual Grant Solicitations outlining grant submission requirements are available via the ODH Website. Solicitations are listed by grant program name and contain the specific information and instructions for application submission by eligible organizations.

If you have any questions pertaining to the specific grant, please contact the Program staff person listed under Programmatic, Technical Assistance and Authorization for Internet Submission in the Application Summary section at the beginning of the Solicitation.

A copy of FY 2021 funding opportunities can be downloaded here.

NOAA’s Office of Ocean Exploration & Research (OER) is soliciting proposals for ocean exploration in waters under U.S. jurisdiction, including the U.S. Exclusive Economic Zone (EEZ). OER is interested in projects that provide data and information that may inform ocean-related segments of the U.S. economy through mapping, characterization, and exploration of the deep seafloor and water column of the U.S. EEZ as well as marine cultural heritage in U.S. waters. OER is soliciting proposals for three themes:

OCEAN EXPLORATION

Ocean exploration to inform management, sustainable use, and conservation of marine resources in poorly explored deep ocean areas of the U.S. EEZ. Areas proposed for exploration and/or initial characterization must be at water depths of 200 m or more.

TECHNOLOGY

Application of new or novel use of existing ocean technologies or innovative methods that increase the scope and efficiency of acquiring ocean exploration data and improve usability of and access to ocean exploration data. Proposed technologies must be applicable to water depths of 200 m or greater, though testing in shallower water or lab-based testing will be supported. Technology testing may occur outside of U.S. waters.

MARINE ARCHAEOLOGY

Discovery and characterization of underwater cultural heritage to inform decisions on preservation and seabed use, and to identify sources of potential environmental impacts. Marine archaeology proposals can be conducted in any water depth within the U.S. EEZ.

Informational documents on this funding opportunity are accessible through the OER website.

For the purpose of this opportunity, costs for ship time and/or other ocean data collection platform support (remotely operated vehicles, autonomous underwater vehicles, etc.) are considered rental costs and therefore are not included in Modified Total Direct Cost (MTDC). The exception is for institutions with a federal negotiated Indirect Cost (IDC) Rate agreement that covers these charges.

Note: Ship time on the NOAA Ship Okeanos Explorer will not be funded through this announcement.